Apontis Pharma AG (ETR:APPH)
Germany · Delayed Price · Currency is EUR 10.85
+0.05 (0.46%)
Aug 1, 2025, 5:36 PM CET
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|---|---|---|---|---|
Single Pills - Hypertension | 25.64M | Log In | Log In | Log In | Log In |
Single Pills - Hypertension Growth | -29.84% | Log In | Log In | Log In | Log In |
Co-Marketing - CO PD (Respiratory Diseases) | 7.96M | Log In | Log In | Log In | Log In |
Co-Marketing - CO PD (Respiratory Diseases) Growth | -20.21% | Log In | Log In | Log In | Log In |
Corporate Brands (without Single Pills) - Other | 2.05M | Log In | Log In | Log In | Log In |
Corporate Brands (without Single Pills) - Other Growth | -3.07% | Log In | Log In | Log In | Log In |
Co-Marketing - Cardiovascular | 1.13M | Log In | Log In | Log In | Log In |
Co-Marketing - Diabetes | 175.00K | Log In | Log In | Log In | Log In |
Co-Marketing - Diabetes Growth | -97.44% | Log In | Log In | Log In | Log In |
Corporate Brands (without Single Pills) - Gynecology | - | Log In | Log In | Log In | Log In |
Corporate Brands (without Single Pills) - Gynecology Growth | - | Log In | Log In | Log In | Log In |
Corporate Brands (without Single Pills) - Vascular | - | Log In | Log In | Log In | Log In |
Corporate Brands (without Single Pills) - Vascular Growth | - | Log In | Log In | Log In | Log In |
Dafiro | - | Log In | Log In | Log In | Log In |
Dafiro Growth | - | Log In | Log In | Log In | Log In |
Corporate Brands (without Single Pills) - Arthritis | - | Log In | Log In | Log In | Log In |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|---|---|---|---|---|
Germany | 36.96M | Log In | Log In | Log In | Log In |
Germany Growth | -33.67% | Log In | Log In | Log In | Log In |